Safety and immunogenicity of a delayed booster dose of the rVSVΔG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial
The Division of Intramural Research and the Division of Clinical Research of the National Institute of Allergy and Infectious Diseases at the US National Institutes of Health, Canadian Immunization Research Network through the Public Health Agency of Canada, Canadian Institutes of Health Research, and the US Defense Threat Reduction Agency.
Authors
- Alain DuChêne
- Nelson Dozier
- Angela Hewlett (ORCID: https://orcid.org/0000-0003-2772-6437)
- Jens H. Kuhn (ORCID: https://orcid.org/0000-0002-7800-6045)
- Marc Teitelbaum
- Susan Moir (ORCID: https://orcid.org/0000-0002-0163-6911)
- Guillaume Poliquin
- Irina Maljkovic Berry (ORCID: https://orcid.org/0000-0001-8555-5352)
- Lindsay Marron (ORCID: https://orcid.org/0000-0002-8062-3560)
- Nadine Rouphael (ORCID: https://orcid.org/0000-0002-2512-7919)
- Bonnie Dighero-Kemp
- Nahid Bhadelia (ORCID: https://orcid.org/0000-0003-4512-2741)
- Lisa E. Hensley (ORCID: https://orcid.org/0000-0003-1188-4342)
- Mark J. Mulligan (ORCID: https://orcid.org/0000-0001-7262-9746)
- Richard T. Davey (ORCID: https://orcid.org/0000-0002-3992-5524)
- Jonathan Kurtz (ORCID: https://orcid.org/0000-0001-9360-4433)
- Surender Khurana (ORCID: https://orcid.org/0000-0002-0593-7965)
- Gabrielle Grubbs (ORCID: https://orcid.org/0000-0003-4302-9535)
- Susan McLellan (ORCID: https://orcid.org/0009-0007-2959-4497)
- Vanessa Raabe (ORCID: https://orcid.org/0000-0003-2579-1104)
- Joanne M. Langley (ORCID: https://orcid.org/0000-0003-3270-7345)
- Gary Collins
- Shawn Brown
- James D. Neaton
- H. Clifford Lane
- Rosemary McConnell
Institutions
- Boston University (US)
- Dalhousie University (CA)
- National Institutes of Health (US)
- University of Minnesota (US)
- Center for Biologics Evaluation and Research (US)
- United States Food and Drug Administration (US)
- Emory University (US)
- Public Health Agency of Canada (CA)
- Izaak Walton Killam Health Centre (CA)
- Nova Scotia Health Authority (CA)
- HOPE Clinic (US)
- Frederick National Laboratory for Cancer Research (US)
- National Institute of Allergy and Infectious Diseases (US)
- National Institutes of Health Clinical Center (US)
- The University of Texas Medical Branch at Galveston (US)
- New York University (US)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- The Lancet Microbe
- Published
- 2024-10-04
- DOI
- https://doi.org/10.1016/s2666-5247(24)00163-0
- Citations
- 5
- Primary Topic
- Viral Infections and Outbreaks Research
- Type
- article
- Field-Weighted Citation Impact
- 1.95
Funders
- U.S. Department of Health and Human Services
- Battelle
- Public Health Agency of Canada
- Frederick National Laboratory for Cancer Research
- Leidos
- Public Health Agency
- Canadian Immunization Research Network
- National Institutes of Health
- Defense Threat Reduction Agency
- Canadian Institutes of Health Research
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases
- NHLBI Division of Intramural Research